AU2002225097A1 - Novel therapeutic use of a thienylcyclohexylamine derivative - Google Patents

Novel therapeutic use of a thienylcyclohexylamine derivative

Info

Publication number
AU2002225097A1
AU2002225097A1 AU2002225097A AU2509702A AU2002225097A1 AU 2002225097 A1 AU2002225097 A1 AU 2002225097A1 AU 2002225097 A AU2002225097 A AU 2002225097A AU 2509702 A AU2509702 A AU 2509702A AU 2002225097 A1 AU2002225097 A1 AU 2002225097A1
Authority
AU
Australia
Prior art keywords
therapeutic use
novel therapeutic
thienylcyclohexylamine
derivative
thienylcyclohexylamine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002225097A
Inventor
Pierre Bernard D'arbigny
Guy Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of AU2002225097A1 publication Critical patent/AU2002225097A1/en
Assigned to IPSEN PHARMA S.A.S reassignment IPSEN PHARMA S.A.S Alteration of Name(s) of Applicant(s) under S113 Assignors: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns the use of a thienylcyclohexylamine, on its own or associated with other substances with pharmaceutical activity, for preparing a medicine designed to prevent and/or treat pain and/or nociception.
AU2002225097A 2000-12-20 2001-12-19 Novel therapeutic use of a thienylcyclohexylamine derivative Abandoned AU2002225097A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0016631A FR2818147B1 (en) 2000-12-20 2000-12-20 NEW THERAPEUTIC APPLICATION OF THIENYCLYCLOHEXYLAMINE DERIVATIVE
FR00/16631 2000-12-20
PCT/FR2001/004050 WO2002049647A2 (en) 2000-12-20 2001-12-19 Novel therapeutic use of a thienylcyclohexylamine derivative

Publications (1)

Publication Number Publication Date
AU2002225097A1 true AU2002225097A1 (en) 2002-07-01

Family

ID=8857906

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002225097A Abandoned AU2002225097A1 (en) 2000-12-20 2001-12-19 Novel therapeutic use of a thienylcyclohexylamine derivative

Country Status (20)

Country Link
US (2) US20050032840A1 (en)
EP (1) EP1359914B1 (en)
JP (1) JP2004525096A (en)
KR (1) KR20030070589A (en)
CN (1) CN1525860A (en)
AT (1) ATE337783T1 (en)
AU (1) AU2002225097A1 (en)
BR (1) BR0116373A (en)
CA (1) CA2432500A1 (en)
CZ (1) CZ20031727A3 (en)
DE (1) DE60122781D1 (en)
FR (1) FR2818147B1 (en)
HU (1) HUP0600063A2 (en)
IL (1) IL156144A0 (en)
MX (1) MXPA03005586A (en)
NO (1) NO20032799L (en)
PL (1) PL365913A1 (en)
RU (1) RU2003122231A (en)
WO (1) WO2002049647A2 (en)
ZA (1) ZA200305538B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858934B1 (en) * 2003-08-22 2006-12-29 Helene Hirbec PHARMACEUTICAL COMPOSITION AND ITS APPLICATION IN THE FIELD OF NEUROLOGY AS A MODULATING AGENT OF THE GLUTAMATERGIC SYSTEM
JP2008531726A (en) * 2005-03-04 2008-08-14 ニューロシステック コーポレイション Improved gacyclidine formulation
FR2946535B1 (en) 2009-06-10 2011-09-09 Neureva COMPOSITION COMPRISING A MOLECULE PROMOTING NEURONE-GLY INTERACTION, IN PARTICULAR FOR PREVENTING THE FORMATION OF THE GLIAL SCAR AND INDUCING NEURAL REGENERATION.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639225B1 (en) * 1988-11-21 1993-05-21 Centre Nat Rech Scient PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION CONTAINING ARYLCYCLOHEXYLAMINES
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5972952A (en) * 1995-12-11 1999-10-26 Le Centre National De La Recherche Scientifique Neuroprotective pharmaceutical composition containing stereoisomers of arylcyclohexylamines
US6784194B2 (en) * 1996-12-06 2004-08-31 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Therapeutic use of a thienylcyclohexylamine derivative

Also Published As

Publication number Publication date
FR2818147A1 (en) 2002-06-21
NO20032799L (en) 2003-08-06
CZ20031727A3 (en) 2004-01-14
EP1359914B1 (en) 2006-08-30
JP2004525096A (en) 2004-08-19
EP1359914A2 (en) 2003-11-12
PL365913A1 (en) 2005-01-10
NO20032799D0 (en) 2003-06-19
ATE337783T1 (en) 2006-09-15
WO2002049647A2 (en) 2002-06-27
DE60122781D1 (en) 2006-10-12
IL156144A0 (en) 2003-12-23
ZA200305538B (en) 2004-09-21
WO2002049647A3 (en) 2003-09-04
MXPA03005586A (en) 2003-10-06
US20090023780A1 (en) 2009-01-22
KR20030070589A (en) 2003-08-30
BR0116373A (en) 2004-07-06
CA2432500A1 (en) 2002-06-27
FR2818147B1 (en) 2005-06-10
RU2003122231A (en) 2005-01-10
CN1525860A (en) 2004-09-01
US20050032840A1 (en) 2005-02-10
HUP0600063A2 (en) 2006-11-28

Similar Documents

Publication Publication Date Title
IL136839A0 (en) Pharmaceutical compositions comprising cannabidiol derivatives
AU7031500A (en) Therapeutic quinazoline compounds
WO2002058684A3 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
YU37602A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
DK0703786T3 (en) Use of nona- and decapeptides for the manufacture of a medicament for the treatment of AIDS
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
WO2003030927A3 (en) Use of thymulin-like peptides for making pain-relieving medicines
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
AU2002213698A1 (en) Needleless syringe for the subcutaneous delivery of therapeutic agents
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU5372199A (en) Cyclopentabenzofuran derivatives and their use
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
WO2002039997A3 (en) Ace-2 modulating compounds and use thereof
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
WO1999018941A3 (en) Ih-MODULATORS
AU2002225097A1 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
HK1079981A1 (en) A pharmaceutical preparation comprising a abacavirand alovudine and use thereof
NO953003L (en) Use of ifenprodil and its diastereoisomers for the preparation of medical preparations
AU1399100A (en) Therapeutic treatment with immunogenic drugs
GC0000336A (en) Pharmaceutical formulation comprising amoxycillin and clavulanate for the treatment of drug resistant s.pneumoniae
UA32315A (en) Technique for skin suturing
WO2000051684A3 (en) Regulators of coenzyme-a-independent transacylase as psychotropic drugs
UA32387A (en) Method for assessment of individual efficacy of anti-arrhythmic drug in patients with supraventricular tachyarrhythmias in setting of accessory conduction tracts

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application